EyePoint Pharmaceuticals Inc. logo

EyePoint Pharmaceuticals Inc.

EYPT | NASDAQ
Chart Builder DCF Calculator
$4.10
+$0.08 (+1.99%)
Sep 22, 2026, 1:20 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
101.82M 99.7M 281.26M 95.63M 178.59M 44.91M
Short-Term Investments
204.27M 271.21M 49.79M 48.93M 32.97M n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
15.12M 5.98M 150K 150K 150K 150K
Receivables
651K 607K 805K 15.5M 18.35M 9.45M
Inventory
1.81M 2.31M 3.91M 2.89M 3.62M 5.34M
Other Current Assets
20.11M 1.41M 1.01M 782K 517K n/a
Total Current Assets
328.66M 383.31M 344.8M 172.81M 237.75M 63.12M
Property-Plant & Equipment
20.22M 29.18M 10.23M 7.4M 2.73M 3.24M
Goodwill & Intangibles
n/a n/a n/a n/a 22.75M 25.21M
Total Long-Term Assets
35.34M 35.16M 10.38M 7.55M 25.63M 28.6M
Total Assets
364M 418.47M 355.18M 180.36M 263.37M 91.72M
Account Payables
10.49M 11.72M 6.5M 5.92M 7.39M 4.81M
Deferred Revenue
n/a 17.78M 38.59M 1.21M 1.07M 945K
Short-Term Debt
n/a n/a n/a 10.48M n/a n/a
Other Current Liabilities
180K 13.27M 13.28M 9.52M 7.32M 5.69M
Total Current Liabilities
37.02M 49.05M 63.26M 34.54M 23.66M 14.89M
Long-Term Debt
n/a n/a n/a 29.31M 36.56M 37.98M
Other Long-Term Liabilities
87K 205K n/a 600K 2.35M 2.37M
Total Long-Term Liabilities
20.86M 32.92M 25.6M 49.45M 55.33M 58.29M
Total Liabilities
57.88M 81.96M 88.86M 83.99M 78.99M 73.18M
Total Debt
22.79M 21.86M 4.91M 46.35M 39.2M 40.99M
Book Value
306.11M 336.5M 266.32M 96.37M 184.38M 18.54M
Book Value Per Share
4.18 5.98 6.85 2.58 6.41 1.44
Common Stock
83K 68K 49K 34K 34K 18K
Retained Earnings
-1.1B -873.02M -742.15M -671.35M -569.1M -510.68M
Comprehensive Income
961K 1.03M 864K 786K 841K 841K
Shareholders Equity
306.11M 336.5M 266.32M 96.37M 184.38M 18.54M
Total Investments
204.27M 271.21M 49.79M 48.93M 32.97M n/a

© 2026 bestshares.com. All rights reserved.